Rapport Therapeutics, Inc. Common Stock (RAPP)

10.12

(3.48%)

Operating Income Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual operating income in 2023 was -36.17 Million USD , down -248.98% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly operating income in 2024 Q2 was -20.8 Million USD , down -21.68% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported an annual operating income of -10.36 Million USD in 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly operating income of -17.09 Million USD for 2024 Q1, down -15.55% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly operating income of -36.17 Million USD for 2023 FY, down -248.98% from previous quarter.

Annual Operating Income Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Created with Highcharts 11.1.0YearsOperating Income20222022.12022.22022.32022.42022.52022.62022.72022.82022.92023-40000000 null-30000000 null-20000000 null-10000000 null

Historical Annual Operating Income of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Operating Income Operating Income Growth
2023 -36.17 Million USD -248.98%
2022 -10.36 Million USD 0.0%

Peer Operating Income Comparison of Rapport Therapeutics, Inc. Common Stock

Name Operating Income Operating Income Difference